Venus Concept Share Price (NASDAQ: VERO)

$2.65

▲

0.2

(8.16%)

Live

Last updated on August 26, 2025 at 1:29 AM IST

$₹

Check the interactive Venus Concept Stock chart to analyse performance

Venus Concept stock performance

as on August 26, 2025 at 1:29 AM IST

Today's Low:$2.40
Today's High:$2.65
$2.65
9.43%
Downside
Day's Volatility :9.43%
Upside
0.0%
52 Weeks Low:$2.10
52 Weeks High:$14.50
$2.65
20.75%
Downside
52 Weeks Volatility :85.52%
Upside
81.72%

Venus Concept Stock Returns

Period	Venus Concept Inc	Index (Russel 2000)
3 Months	6.52%	0.0%
6 Months	-27.21%	0.0%
1 Year	-59.65%	0.0%
3 Years	-95.74%	-10.0%

Venus Concept Inc Key Stats

Check Venus Concept key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.45
Open	$2.42
Today's High	$2.6
Today's Low	$2.4
Market Capitalization	$4.5M
Today's Volume	$29.6K
52 Week High	$14.5
52 Week Low	$2.1
Revenue TTM	$60.1M
EBITDA	$-28.6M
Earnings Per Share (EPS)	$-44.79
Profit Margin	-68.77%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1161.04%

Stock Returns calculator for Venus Concept Stock including INR - Dollar returns

The Venus Concept stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Venus Concept investment value today

Current value as on today

₹48,013

Returns

₹51,987

(-51.99%)

Returns from Venus Concept Stock

₹56,343 (-56.34%)

Dollar Returns*

₹4,355 (+4.36%)

Indian investors sentiment towards Venus Concept Stock

-43%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Venus Concept Stock from India on INDmoney has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Venus Concept Inc

Name
Holdings %
Name
Holdings %
Essex Woodlands Health Ventures
5.33%
UBS Group AG
0.49%
Tower Research Capital LLC
0.21%

Analyst Recommendation on Venus Concept Stock

Rating

Trend

Hold

0%Buy

62%Hold

37%Sell

Based on 8 Wall street analysts offering stock ratings for Venus Concept(by analysts ranked 0 to 5 stars)

Venus Concept Share Price Target

What analysts predicted

Upside of 300.0%

Target:

$10.60

Current:

$2.65

Venus Concept share price target is $10.60, a slight Upside of 300.0% compared to current price of $2.65 as per analysts' prediction.

Venus Concept Stock Insights

Price Movement
In the last 6 months, VERO stock has moved down by -58.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 13.64M → 15.69M (in $), with an average increase of 13.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -12.36M → -11.72M (in $), with an average increase of 5.5% per quarter
VERO vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 34.1% return, outperforming this stock by 95.5%
VERO vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 154.1% return, outperforming this stock by 250.2%
Price to Sales
ForVERO every $1 of sales, investors are willing to pay $0.0, whereas for Boston Scientific Corp., the investors are paying $8.5 for every $1 of sales.

Venus Concept Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$110.4M	↑ 402.85%
Net Income	$-42.3M	↑ 47.24%
Net Profit Margin	-38.31%	↑ 92.52%

	FY20	Y/Y Change
Revenue	$78.0M	↓ 29.34%
Net Income	$-82.8M	↑ 95.81%
Net Profit Margin	-106.16%	↓ 67.85%

	FY21	Y/Y Change
Revenue	$105.6M	↑ 35.39%
Net Income	$-22.1M	↓ 73.27%
Net Profit Margin	-20.96%	↑ 85.2%

	FY22	Y/Y Change
Revenue	$99.5M	↓ 5.8%
Net Income	$-43.6M	↑ 96.85%
Net Profit Margin	-43.8%	↓ 22.84%

	FY23	Y/Y Change
Revenue	$76.4M	↓ 23.26%
Net Income	$-37.3M	↓ 14.53%
Net Profit Margin	-48.79%	↓ 4.99%

	FY24	Y/Y Change
Revenue	$64.8M	↓ 15.09%
Net Income	$-47.0M	↑ 26.16%
Net Profit Margin	-72.49%	↓ 23.7%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$17.5M	↓ 3.6%
Net Income	$-9.8M	↓ 11.89%
Net Profit Margin	-56.03%	↑ 5.28%

	Q2 FY24	Q/Q Change
Revenue	$16.6M	↓ 5.13%
Net Income	$-20.0M	↑ 103.71%
Net Profit Margin	-120.32%	↓ 64.29%

	Q3 FY24	Q/Q Change
Revenue	$15.0M	↓ 9.5%
Net Income	$-9.3M	↓ 53.46%
Net Profit Margin	-61.88%	↑ 58.44%

	Q4 FY24	Q/Q Change
Revenue	$15.8M	↑ 5.05%
Net Income	$-8.0M	↓ 14.23%
Net Profit Margin	-50.52%	↑ 11.36%

	Q1 FY25	Q/Q Change
Revenue	$13.6M	↓ 13.46%
Net Income	$-12.4M	↑ 55.22%
Net Profit Margin	-90.62%	↓ 40.1%

	Q2 FY25	Q/Q Change
Revenue	$15.7M	↑ 15.02%
Net Income	$-11.7M	↓ 5.19%
Net Profit Margin	-74.69%	↑ 15.93%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$76.7M	↑ 706.36%

	FY20	Y/Y Change
Profit	$51.4M	↓ 32.96%

	FY21	Y/Y Change
Profit	$74.1M	↑ 44.18%

	FY22	Y/Y Change
Profit	$66.0M	↓ 10.96%

	FY23	Y/Y Change
Profit	$52.2M	↓ 20.92%

	FY24	Y/Y Change
Profit	$44.3M	↓ 15.07%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$11.6M	↓ 3.45%

	Q2 FY24	Q/Q Change
Profit	$11.8M	↑ 1.73%

	Q3 FY24	Q/Q Change
Profit	$9.9M	↓ 16.27%

	Q4 FY24	Q/Q Change
Profit	$10.9M	↑ 9.76%

	Q1 FY25	Q/Q Change
Profit	$8.8M	↓ 19.6%

	Q2 FY25	Q/Q Change
Profit	$9.4M	↑ 7.72%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-39.6M	↑ 37.97%
Investing Cash Flow	$6.4M	↓ 734.59%
Financing Cash Flow	$42.2M	↑ 89.79%

	FY20	Y/Y Change
Operating Cash Flow	$-28.7M	↓ 27.64%
Investing Cash Flow	$-2.4M	↓ 137.47%
Financing Cash Flow	$49.7M	↑ 17.7%

	FY21	Y/Y Change
Operating Cash Flow	$-19.8M	↓ 30.99%
Investing Cash Flow	$-552.0K	↓ 76.92%
Financing Cash Flow	$16.8M	↓ 66.14%

	FY22	Y/Y Change
Operating Cash Flow	$-27.0M	↑ 36.46%
Investing Cash Flow	$-336.0K	↓ 39.13%
Financing Cash Flow	$8.0M	↓ 52.38%

	FY23	Y/Y Change
Operating Cash Flow	$-12.9M	↓ 52.34%
Investing Cash Flow	$-116.0K	↓ 65.48%
Financing Cash Flow	$6.8M	↓ 15.07%

	FY24	Y/Y Change
Operating Cash Flow	$-11.1M	↓ 13.94%
Investing Cash Flow	$-123.0K	↑ 6.03%
Financing Cash Flow	$10.1M	↑ 47.96%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-2.9M	↑ 271.83%
Investing Cash Flow	$-25.0K	-
Financing Cash Flow	$2.6M	↑ 104.09%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-1.3M	↓ 53.72%
Investing Cash Flow	$-22.0K	↓ 12.0%
Financing Cash Flow	$2.0M	↓ 22.94%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-3.0M	↑ 128.9%
Investing Cash Flow	$4.0K	↓ 118.18%
Financing Cash Flow	$1.8M	↓ 9.85%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-3.8M	↑ 24.86%
Investing Cash Flow	$-80.0K	↓ 2100.0%
Financing Cash Flow	$3.7M	↑ 103.61%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-6.3M	↑ 65.75%
Investing Cash Flow	$-35.0K	↓ 56.25%
Financing Cash Flow	$5.3M	↑ 43.72%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-5.4M	↓ 13.66%
Investing Cash Flow	$-162.0K	↑ 362.86%
Financing Cash Flow	$7.3M	↑ 37.99%

Venus Concept Technicals Summary

Sell

Neutral

Buy

Venus Concept is currently in a neutral trading position according to technical analysis indicators.

Venus Concept Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Venus Concept Inc	-3.54%	-27.21%	-59.65%	-95.74%	-99.52%
Medtronic Plc	0.8%	2.82%	3.77%	3.67%	-10.92%
Edwards Lifesciences Corp.	4.26%	12.47%	19.03%	-10.31%	0.38%
Boston Scientific Corp.	0.31%	1.71%	33.6%	162.02%	169.81%
Stryker Corporation	-1.61%	1.62%	11.27%	90.44%	108.57%
Abbott Laboratories	4.94%	-1.75%	17.65%	30.12%	28.49%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Venus Concept Inc	NA	NA	NA	-17.65	-11.61	-0.28	NA	1.25
Medtronic Plc	25.61	25.61	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	34.24	34.24	4.89	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	63.2	63.2	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	52.08	52.08	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Venus Concept Inc	Hold	$4.5M	-99.52%	NA	-68.77%
Medtronic Plc	Buy	$118.8B	-10.92%	25.61	13.63%
Edwards Lifesciences Corp.	Buy	$48.0B	0.38%	34.24	72.96%
Boston Scientific Corp.	Buy	$157.3B	169.81%	63.2	13.55%
Stryker Corporation	Buy	$150.7B	108.57%	52.08	12.25%
Abbott Laboratories	Buy	$230.8B	28.49%	16.64	32.43%

About Venus Concept Inc

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Organization	Venus Concept
Employees	292
CEO	Mr. Rajiv Kanishka Liyanaarchchie De Silva
Industry	Health Technology

Key Management of Venus Concept Inc

Name	Title
Mr. Rajiv Kanishka Liyanaarchchie De Silva	CEO & Director
Mr. Ross J. Portaro	Executive VP of Commercial Strategy & Head of Venus Hair
Mr. Domenic Della Penna CPA	Executive VP & CFO
Mr. Michael Mandarello	Chief Legal Officer, Head of Strategy & Operations
Ms. Anna Georgiadis	Chief Human Resources Officer
Ms. Melissa Kang	Chief Product Officer
Ms. Joyce Morris	Head of Sales - Canada
Mr. Ognjen Petrovic	Head of R&D, Robotics, Software
Mr. Cliff Oostman	Head of R&D, Robotics, Hardware
Mr. Jesus Alvarez-Quintero	Head of Sales - LATAM

Important FAQs about investing in VERO Stock from India :

What is Venus Concept share price today?

Venus Concept share price today is $2.65 as on August 26, 2025 at 1:29 AM IST. Venus Concept share today touched a day high of $2.65 and a low of $2.40.

What is the 52 week high and 52 week low for Venus Concept share?

Venus Concept share touched a 52 week high of $14.50 and a 52 week low of $2.10. Venus Concept stock price today i.e. August 26, 2025 at 1:29 AM IST is trending at $2.65, lower by 81.72% versus the 52 week high.

How to invest in Venus Concept Stock (VERO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Venus Concept on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Venus Concept Shares that will get you 0.5660 shares as per Venus Concept share price of $2.65 per share as on August 26, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Venus Concept Stock (VERO) from India?

Indian investors can start investing in Venus Concept (VERO) shares with as little as ₹87.554 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.54 in Venus Concept stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Venus Concept share’s latest price of $2.65 as on August 26, 2025 at 1:29 AM IST, you will get 3.7736 shares of Venus Concept. Learn more about fractional shares .

What are the returns that Venus Concept has given to Indian investors in the last 5 years?

Venus Concept stock has given -99.52% share price returns and 18.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?